Tumor microenvironment: barrier or opportunity towards effective cancer therapy

Микросреда опухоли: барьер или возможность для эффективной терапии рака
Shiaw‐Yih Lin, Aadhya Tiwari, Rakesh Trivedi
2022-10-17

3D culture modelsbioinformatic profiling of TMEimmune cell diversityneoantigen predictiontumor microenvironment (TME)
Tumor microenvironment (TME) is a specialized ecosystem of host components, designed by tumor cells for successful development and metastasis of tumor. With the advent of 3D culture and advanced bioinformatic methodologies, it is now possible to study TME's individual components and their interplay at higher resolution. Deeper understanding of the immune cell's diversity, stromal constituents, repertoire profiling, neoantigen prediction of TMEs has provided the opportunity to explore the spatial and temporal regulation of immune therapeutic interventions. The variation of TME composition among patients plays an important role in determining responders and non-responders towards cancer immunotherapy. Therefore, there could be a possibility of reprogramming of TME components to overcome the widely prevailing issue of immunotherapeutic resistance. The focus of the present review is to understand the complexity of TME and comprehending future perspective of its components as potential therapeutic targets. The later part of the review describes the sophisticated 3D models emerging as valuable means to study TME components and an extensive account of advanced bioinformatic tools to profile TME components and predict neoantigens. Overall, this review provides a comprehensive account of the current knowledge available to target TME.
1
Advances in 3D culture and bioinformatic methods now allow higher-resolution study of individual TME components and their interactions.
2
Deep profiling of immune diversity, stromal constituents, repertoire sequencing, and neoantigen prediction enables exploration of spatial and temporal regulation of immune therapies.
3
Inter-patient variation in TME composition significantly influences responders versus non-responders to cancer immunotherapy, suggesting predictive potential.
4
Reprogramming TME components is a plausible strategy to overcome immunotherapeutic resistance, and 3D models plus bioinformatic tools are valuable for identifying therapeutic targets.
5
Tumor microenvironment (TME) comprises diverse host components arranged by tumor cells that critically enable tumor development and metastasis.

Tumor microenvironment (TME)

Composition, cellular and molecular complexity, spatial-temporal regulation, and targetability of TME components for improving cancer immunotherapy and overcoming immunotherapeutic resistance, including modeling via 3D culture and profiling with advanced bioinformatic tools

Publication Details
Publication Date
2022-10-17
Journal
Publisher
ISSN
Cited by
391
Access Type
Author Information
Authors
Shiaw‐Yih Lin
Aadhya Tiwari
Rakesh Trivedi
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%